UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 447

Sortiert nach

Soluble HLA-G expression and renal graft acceptance

American journal of transplantation, 2006-09, Vol.6 (9), p.2152-2156

2006

Volltextzugriff (PDF)

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G

European urology, 2015-08, Vol.68 (2), p.267-279

2015

Volltextzugriff (PDF)

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

Blood, 2008-05, Vol.111 (10), p.4862-4870

2008

Volltextzugriff (PDF)

The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells

Blood, 2011-12, Vol.118 (25), p.6499-6505

2011

Volltextzugriff (PDF)

Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population

PloS one, 2013-10, Vol.8 (10), p.e71742-e71742

2013

Volltextzugriff (PDF)

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17

Blood, 2011-06, Vol.117 (26), p.7021-7031

2011

Volltextzugriff (PDF)

Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses

The Journal of immunology (1950), 2014-02, Vol.192 (4), p.1536-1546

2014

Volltextzugriff (PDF)

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction

Leukemia, 2012-08, Vol.26 (8), p.1889-1892

2012

Volltextzugriff (PDF)

HLA-G/LILRBs: A Cancer Immunotherapy Challenge

Trends in cancer, 2021-05, Vol.7 (5), p.389-392

2021

Volltextzugriff (PDF)

The Dual Role of HLA-G in Cancer

Journal of Immunology Research, 2014-01, Vol.2014, p.359748-10

2014

Volltextzugriff (PDF)

HLA-G: from biology to clinical benefits

Trends in immunology, 2008-03, Vol.29 (3), p.125-132

2008

Volltextzugriff (PDF)

HLA-G1-Expressing Antigen-Presenting Cells Induce Immunosuppressive CD4+ T Cells

Proceedings of the National Academy of Sciences - PNAS, 2004-05, Vol.101 (18), p.7064-7069

2004

Volltextzugriff (PDF)

Kidney Transplant Recipients Treated With Belatacept Exhibit Increased Naïve and Transitional B Cells

American journal of transplantation, 2014-05, Vol.14 (5), p.1173-1182

2014

Volltextzugriff (PDF)

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

BMC cancer, 2020-07, Vol.20 (1), p.624-11, Article 624

2020

Volltextzugriff (PDF)

Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion

Viruses, 2021-09, Vol.13 (9), p.1855

2021

Volltextzugriff (PDF)

HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis

The Journal of immunology (1950), 2001-04, Vol.166 (8), p.5018-5026

2001

Volltextzugriff (PDF)

Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially

PloS one, 2017-01, Vol.12 (1), p.e0169032-e0169032

2017

Volltextzugriff (PDF)

On the Definition of a Criterion of Immunogenicity

Proceedings of the National Academy of Sciences - PNAS, 2006-11, Vol.103 (47), p.17858-17861

2006

Volltextzugriff (PDF)

Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway

Proceedings of the National Academy of Sciences - PNAS, 2008-06, Vol.105 (24), p.8357-8362

2008

Volltextzugriff (PDF)

Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy

Stem cells (Dayton, Ohio), 2013-11, Vol.31 (11), p.2296-2303

2013

Volltextzugriff (PDF)

Trogocytosis-based generation of suppressive NK cells

The EMBO journal, 2007-03, Vol.26 (5), p.1423-1433

2007

Volltextzugriff (PDF)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary

Frontiers in immunology, 2020-08, Vol.11, p.2046-2046

2020

Volltextzugriff (PDF)

Soluble HLA-G Protein Secreted by Allo-Specific CD4+T Cells Suppresses the Allo-Proliferative Response: A CD4+T Cell Regulatory Mechanism

Proceedings of the National Academy of Sciences - PNAS, 2001-10, Vol.98 (21), p.12150-12155

2001

Volltextzugriff (PDF)

Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3351

2020

Volltextzugriff (PDF)

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G

Leukemia, 2008-05, Vol.22 (5), p.998-1006

2008

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(395)
Mit Volltextzugriff
(398)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(280)
Humans
(266)
Life Sciences & Biomedicine
(241)
Hla-G Antigens
(143)
Immunology
(127)
Female
(109)
Biological And Medical Sciences
(94)
Hla-G
(85)
Histocompatibility Antigens Class I - Genetics
(73)
Hla Antigens - Genetics
(73)
Hla Antigens - Immunology
(72)
Histocompatibility Antigens Class I - Immunology
(69)
Male
(62)
Medical Sciences
(59)
Pregnancy
(48)
Adult
(46)
Histocompatibility Antigens Class I - Metabolism
(46)
Hla Antigens - Metabolism
(46)
Histocompatibility Antigen Hla
(44)
Middle Aged
(44)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Soluble HLA-G expression and renal graft acceptance

A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells

Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17

Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses

Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction

HLA-G/LILRBs: A Cancer Immunotherapy Challenge

The Dual Role of HLA-G in Cancer

HLA-G: from biology to clinical benefits

HLA-G1-Expressing Antigen-Presenting Cells Induce Immunosuppressive CD4+ T Cells

Kidney Transplant Recipients Treated With Belatacept Exhibit Increased Naïve and Transitional B Cells

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion

HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis

Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially

On the Definition of a Criterion of Immunogenicity

Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway

Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy

Trogocytosis-based generation of suppressive NK cells

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary

Soluble HLA-G Protein Secreted by Allo-Specific CD4+T Cells Suppresses the Allo-Proliferative Response: A CD4+T Cell Regulatory Mechanism

Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G

Suchergebnisse filtern